New York legislation · 2025-2026 General Assembly
New York A11628: Requires insurance coverage for FDA approved expanded access to certain investigational medical products
Status: In committee, July 29, 2026
Requires insurance policies to provide coverage for federal food and drug administration approved expanded access to an investigational medical product that has been shown to be effective, without the need for any prior authorization determination.
What the bill says
An act to amend the insurance law, in relation to requiring insurance coverage for federal food and drug administration approved expanded access to certain investigational medical products.
From the introduced text, July 29, 2026:
AN ACT to amend the insurance law, in relation to requiring insurance coverage for federal food and drug administration approved expanded access to certain investigational medical products THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEMBLY, DO ENACT AS FOLLOWS: Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 42 to read as follows: (42) EVERY POLICY THAT PROVIDES MEDICAL, MAJOR MEDICAL, OR SIMILAR COMPREHENSIVE TYPE COVERAGE SHALL INCLUDE COVERAGE FOR FEDERAL FOOD AND DRUG ADMINISTRATION APPROVED EXPANDED ACCESS TO AN INVESTIGATIONAL MEDICAL PRODUCT THAT HAS BEEN SHOWN TO BE EFFECTIVE, WITHOUT THE NEED FOR ANY PRIOR AUTHORIZATION DETERMINATION. § 2. Subsection (l) of section 3221 of the insurance law is amended by adding a new paragraph 24 to read as follows: (24) EVERY GROUP OR BLANKET POLICY THAT PROVIDES MEDICAL, MAJOR MEDICAL, OR SIMILAR COMPREHENSIVE TYPE COVERAGE SHALL INCLUDE COVERAGE FOR FEDERAL FOOD AND DRUG ADMINISTRATION APPROVED EXPANDED ACCESS TO AN INVESTIGATIONAL MEDICAL PRODUCT THAT HAS BEEN SHOWN TO BE EFFECTIVE, WITHOUT THE NEED FOR ANY PRIOR AUTHORIZATION DETERMINATION. § 3. Section 4303 of the insurance law is amended by adding a new subsection (22) to read as follows: (22) EVERY CONTRACT ISSUED BY A MEDICAL EXPENSE INDEMNITY CORPORATION, HOSPITAL SERVICE CORPORATION, OR HEALTH SERVICE CORPORATION …
Sponsors
- Kalman Yeger (D, 41) · primary sponsor
Latest actions
- : REFERRED TO INSURANCE
Subjects: Insurance Law
Common questions
- What is A11628?
- A11628 is a bill in the New York Legislature (2025-2026 General Assembly): Requires insurance coverage for FDA approved expanded access to certain investigational medical products.
- What does A11628 do?
- In its own words: An act to amend the insurance law, in relation to requiring insurance coverage for federal food and drug administration approved expanded access to certain investigational medical products.
- What is the status of A11628?
- In committee as of July 29, 2026. Latest action: REFERRED TO INSURANCE (July 29, 2026).
- Who sponsored A11628?
- Kalman Yeger (D, 41).
- Where is the official record for A11628?
- On the New York Legislature website: https://www.nysenate.gov/legislation/bills/2025/A11628
Source: official New York record. Tracked by Delilah, AI for legislation across all 50 states and Congress.